25-OH-Vitamin D in experimental and clinical uremia.

Suppr

超能文献

作者信息

Schmidt-Gayk H, Ritz E, Mehls O, Goossen J, Förster P

出版信息

Calcif Tissue Res. 1977 May;22 Suppl:430-3. doi: 10.1007/BF02064121.

DOI:10.1007/BF02064121

PMID:912563

Abstract

摘要

相似文献

25-OH-Vitamin D in experimental and clinical uremia.

Calcif Tissue Res. 1977 May;22 Suppl:430-3. doi: 10.1007/BF02064121.

Serum 25-hydroxycholecalciferol in uremia.尿毒症患者血清25-羟胆钙化醇水平

Nephron. 1974;13(4):269-77. doi: 10.1159/000180403.

Serum concentrations of 24,25(OH)2D in uremic children: a reflection of renal function.尿毒症患儿血清24,25(OH)₂D浓度：肾功能的一种反映

J Pediatr. 1979 Feb;94(2):190-3. doi: 10.1016/s0022-3476(79)80820-3.

Elevated thrombocyte calcium content in uremia and its correction by 1 alpha(OH) vitamin D treatment.尿毒症患者血小板钙含量升高及其经 1α(OH)维生素 D 治疗后的纠正

Nephron. 1982;30(3):237-9. doi: 10.1159/000182471.

Serum 25-hydroxycholecalciferol in Greek uremics.希腊尿毒症患者的血清25-羟胆钙化醇

Invest Urol. 1980 Jul;18(1):52-3.

Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.1α-羟基维生素D3与高剂量碳酸钙对维持性透析患者甲状旁腺功能亢进和高铝血症控制效果的比较

Nephron. 1985;39(4):309-15. doi: 10.1159/000183396.

Parathyroid hormone-, 25-OH-vitamin D-, and digoxin levels in patients treated by chronic hemofiltration.接受慢性血液滤过治疗患者的甲状旁腺激素、25-羟基维生素D和地高辛水平。

J Dial. 1977;1(6):619-30. doi: 10.3109/08860227709037657.

[Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].[尿毒症性骨病的治疗。维生素D代谢产物和维生素D类似物在慢性尿毒症和实验性肾功能不全中的作用]

MMW Munch Med Wochenschr. 1974 Sep 13;116(37):1573-8.

Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.

Contrib Nephrol. 1980;18:98-104. doi: 10.1159/000403277.

1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。

Dan Med Bull. 2008 Nov;55(4):186-210.

引用本文的文献

Do patients who are treated with calcitriol for renal osteodystrophy also need vitamin D3 therapy?

Pediatr Nephrol. 1995 Apr;9(2):136. doi: 10.1007/BF00860725.

Recent advances and controversies in childhood renal osteodystrophy.儿童肾性骨营养不良的最新进展与争议

Pediatr Nephrol. 1987 Apr;1(2):212-23. doi: 10.1007/BF00849295.

本文引用的文献

Plasma 25-hydroxycholecalciferol in chronic renal failure.

Eur J Clin Invest. 1973 Dec;3(6):447-50. doi: 10.1111/j.1365-2362.1973.tb02213.x.

Effect of experimental chronic renal insufficiency on bone mineral and collagen maturation.实验性慢性肾功能不全对骨矿物质及胶原成熟的影响。

J Clin Invest. 1972 Dec;51(12):3072-9. doi: 10.1172/JCI107134.

Serum 25-hydroxycholecalciferol in uremia.尿毒症患者血清25-羟胆钙化醇水平

Nephron. 1974;13(4):269-77. doi: 10.1159/000180403.

The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans.正常人和无肾者体内维生素D3和25-羟基维生素D3的代谢

J Clin Endocrinol Metab. 1974 Dec;39(6):1045-56. doi: 10.1210/jcem-39-6-1045.

Competitive protein-binding assay for 25-hydroxycholecalciferol.25-羟胆钙化醇的竞争性蛋白结合测定法。

Clin Sci Mol Med. 1974 Feb;46(2):231-40. doi: 10.1042/cs0460231.

The metabolic fate of vitamin D3-3H in chronic renal failure.维生素D3-3H在慢性肾衰竭中的代谢归宿。

J Clin Invest. 1968 Oct;47(10):2239-52. doi: 10.1172/JCI105909.

[Diagnosis of anticonvulsant osteomalacia in adults (author's transl)].

Dtsch Med Wochenschr. 1977 Dec 23;102(51):1872-7. doi: 10.1055/s-0028-1105588.

Letter: 25-Hydroxycholecalciferol in chronic renal failure.

Lancet. 1975 Aug 23;2(7930):372. doi: 10.1016/s0140-6736(75)92822-6.

Letter: Vitamin-D metabolism in chronic renal failure.

Lancet. 1975 Apr 26;1(7913):981. doi: 10.1016/s0140-6736(75)92047-4.

Letter: vitamin-D metabolism in chronic renal failure.

Lancet. 1975 Mar 1;1(7905):516-7. doi: 10.1016/s0140-6736(75)92854-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验